An efficacy trial of the malaria vaccine SPf66 in Gambian infants - second year of follow-up

被引:12
作者
Bojang, KA
Obaro, SK
DAlessandro, U
Bennett, S
Langerock, P
Targett, GAT
Greenwood, BM
机构
[1] LONDON SCH HYG & TROP MED,LONDON WC1,ENGLAND
[2] MRC LABS,FAJARA,GAMBIA
[3] INST TROP MED PRINCE LEOPOLD,B-2000 ANTWERP,BELGIUM
基金
英国医学研究理事会;
关键词
malaria; Plasmodium falciparum; malaria vaccine; SPf66;
D O I
10.1016/S0264-410X(97)00159-X
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In 1994, 630 Gambian infants were immunized with three doses of the synthetic polypeptide malaria vaccine SPf66 or with a control vaccine. No significant protection against first or total attacks of malaria was observed among the children who received SPf66. However the period of follow-up was short. Thus, 532 children were followed for a second malaria transmission season during which 291 episodes of malaria were detected. Protective efficacies of SPf66 against first attacks of malaria and against all attacks of malaria were 8% [95% CI -20%, 30%] and 2% [95% CI -26% 24%] respectively. SPf66 did not provide any significant degree of protection to Gambian infants during a second year of follow-up. (C) 1997 Elsevier Science Ltd.
引用
收藏
页码:62 / 67
页数:6
相关论文
共 15 条
[1]   Duration of protection and age-dependence of the effects of the SPf66 malaria vaccine in African children exposed to intense transmission of Plasmodium falciparum [J].
Alonso, PL ;
Smith, TA ;
ArmstrongSchellenberg, JRM ;
Kitua, AY ;
Masanja, H ;
Hayes, R ;
Hurt, N ;
Font, F ;
Menendez, C ;
Kilama, WL ;
Tanner, M .
JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (02) :367-372
[2]   RANDOMIZED TRIAL OF EFFICACY OF SPF66 VACCINE AGAINST PLASMODIUM-FALCIPARUM MALARIA IN CHILDREN IN SOUTHERN TANZANIA [J].
ALONSO, PL ;
SMITH, T ;
SCHELLENBERG, JRMA ;
MASANJA, H ;
MWANKUSYE, S ;
URASSA, H ;
DEAZEVEDO, IB ;
CHONGELA, J ;
KOBERO, S ;
MENENDEZ, C ;
HURT, N ;
THOMAS, MC ;
LYIMO, E ;
WEISS, NA ;
HAYES, R ;
KITUA, AY ;
LOPEZ, MC ;
KILAMA, WL ;
TEUSCHER, T ;
TANNER, M .
LANCET, 1994, 344 (8931) :1175-1181
[3]  
BECK HP, 1995, AM J TROP MED HYG, V53, P284
[4]   MEROZOITE SURFACE ANTIGEN-I OF PLASMODIUM [J].
COOPER, JA .
PARASITOLOGY TODAY, 1993, 9 (02) :50-54
[5]   EFFICACY TRIAL OF MALARIA VACCINE SPF66 IN GAMBIAN INFANTS [J].
DALESSANDRO, U ;
LEACH, A ;
DRAKELEY, CJ ;
BENNETT, S ;
OLALEYE, BO ;
FEGAN, GW ;
JAWARA, M ;
LANGEROCK, P ;
GEORGE, MO ;
TARGETT, GAT ;
GREENWOOD, BM .
LANCET, 1995, 346 (8973) :462-467
[6]   COMPARISON OF 2 SIMPLE METHODS FOR DETERMINING MALARIA PARASITE DENSITY [J].
GREENWOOD, BM ;
ARMSTRONG, JRM .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1991, 85 (02) :186-188
[7]  
LEACH A, 1965, PARASITE IMMUNOL, V17, P441
[8]   A SPECIFIC T-CELL RECEPTOR GENOTYPE PREFERENCE IN THE IMMUNE-RESPONSE TO A SYNTHETIC PLASMODIUM-FALCIPARUM MALARIA VACCINE [J].
MURILLO, LA ;
TENJO, FA ;
CLAVIJO, OP ;
OROZCO, MA ;
SAMPAIO, S ;
KALIL, J ;
PATARROYO, ME .
PARASITE IMMUNOLOGY, 1992, 14 (01) :87-94
[9]   Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in northwestern Thailand [J].
Nosten, F ;
Luxemburger, C ;
Kyle, DE ;
Ballou, WR ;
Wittes, J ;
Wah, E ;
Chongsuphajaisiddhi, T ;
Gordon, DM ;
White, NJ ;
Sadoff, JC ;
Heppner, DG ;
Bathe, K ;
Blood, J ;
Brockman, A ;
Cobley, UT ;
Hacking, D ;
Hogg, D ;
U, KH ;
Maelankiri, L ;
Chuanak, N ;
Permpanich, B ;
Price, R ;
Raimond, D ;
Schabenberger, O ;
Singharaj, P ;
Singhasivanon, P ;
Slight, T ;
Tulayon, S ;
Tway, KL ;
Ynint, T ;
VincentiDelmas, M ;
deVries, A ;
Webster, HK .
LANCET, 1996, 348 (9029) :701-707
[10]   A POPULATION-BASED CLINICAL-TRIAL WITH THE SPF66 SYNTHETIC PLASMODIUM-FALCIPARUM MALARIA VACCINE IN VENEZUELA [J].
NOYA, O ;
BERTI, YG ;
DENOYA, BA ;
BORGES, R ;
ZERPA, N ;
URBAEZ, JD ;
MADONNA, A ;
GARRIDO, E ;
JIMENEZ, MA ;
BORGES, RE ;
GARCIA, P ;
REYES, I ;
PRIETO, W ;
COLMENARES, C ;
PABON, R ;
BARRAEZ, T ;
DECACERES, LG ;
GODOY, N ;
SIFONTES, R .
JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (02) :396-402